Neurology · Florence, SC
NPI
1871609388
Since 2006
Specialty
Neurology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
436 W Palmetto St
Florence, SC, 29501
Phone (843) 669-2007
Groups this clinician bills Medicare through
Medicare paid, 2024
$105K
1,190 services
Medicare patients, 2024
387
Average age 70
Drug cost, 2024
$6.2M
7,130 prescriptions
Company payments, 2025
$3,586
From 37 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Walter J Evans was code 99214 (office e&m - established), 645 times for 327 patients. In total Walter J Evans billed 1,190 services in 25 codes, and Medicare paid $105K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-01-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 645 | 327 | $82.68 | $53K |
| 70551 MRI/MRA - Head and Neck | Office | 115 | 92 | $46.98 | $5,402 |
| 99204 Office E&M - New | Office | 82 | 82 | $108.51 | $8,898 |
| 95816 Neurologic | Office | 55 | 54 | $278.21 | $15K |
| 95886 Electrical Nerve Conductivity | Office | 54 | 42 | $66.80 | $3,607 |
| 99212 Office E&M - Established | Office | 40 | 32 | $39.10 | $1,564 |
| 93922 Duplex Scan - Extremity Arteries | Office | 34 | 17 | $56.30 | $1,914 |
| 99213 Office E&M - Established | Office | 30 | 21 | $59.00 | $1,770 |
| 95909 Electrical Nerve Conductivity | Office | 24 | 24 | $94.88 | $2,277 |
| 95923 Electrical Nerve Conductivity | Office | 17 | 17 | $88.78 | $1,509 |
| 72141 MRI/MRA - Spine | Office | 15 | 15 | $43.68 | $655 |
| 99205 Office E&M - New | Office | 14 | 14 | $139.80 | $1,957 |
| 95913 Electrical Nerve Conductivity | Office | 12 | 12 | $178.65 | $2,144 |
By year: 2022 $139K for 1,311 services; 2023 $122K for 1,249 services; 2024 $105K for 1,190 services.
Medicare prescription drug claims, 2024
In 2024, the drug Walter J Evans prescribed most often to Medicare patients was Gabapentin, with 372 prescriptions and refills. In total Walter J Evans wrote 7,130 Medicare prescriptions that cost $6.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 372 | 448 | 71 | $4,289 |
| Donepezil Hcl Generic | 308 | 467 | 74 | $2,804 |
| Topiramate Generic | 305 | 482 | 74 | $4,854 |
| Briviact Brivaracetam | 248 | 250 | 22 | $365K |
| Oxcarbazepine Generic | 247 | 315 | 48 | $15K |
| Memantine Hcl Generic | 197 | 213 | 45 | $3,035 |
| Clonazepam Generic | 195 | 217 | 32 | $1,476 |
| Pregabalin Generic | 191 | 198 | 38 | $4,664 |
| Levetiracetam Generic | 186 | 280 | 36 | $4,955 |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | 180 | 181 | 37 | $7,837 |
| Alprazolam Generic | 170 | 179 | 21 | $880 |
| Phenobarbital Generic | 149 | 150 | 14 | $2,702 |
| Cyclobenzaprine Hcl Generic | 146 | 157 | 33 | $1,572 |
| Lacosamide Generic | 134 | 144 | 16 | $7,279 |
| Baclofen Generic | 130 | 175 | 29 | $2,131 |
Brand drugs: 1,430 claims; generic drugs: 5,551 claims; opioid claims: 75.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Walter J Evans $3,586 ($3,586 in general payments such as food, travel and fees) from 37 companies. The largest payer was UCB, Inc. with $375.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 17 | $375 |
| Teva Pharmaceuticals USA, Inc. TEVA | 29 | $303 |
| Abbvie Inc. ABBV | 14 | $217 |
| Pfizer Inc. PFE | 13 | $200 |
| Neurocrine BioSciences, Inc. NBIX | 10 | $197 |
| Biogen, Inc. BIIB | 9 | $188 |
| Alexion Pharmaceuticals, Inc. AZN | 7 | $171 |
| EMD Serono, Inc. MRK.DE | 7 | $158 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $130 |
| SK Life Science, Inc. | 6 | $123 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.